Sunitinib

Chemical compound

Last price

—

Floor price

—

7-day median

—

30-day sales

30-day range

—

In circulation

Price history

Show table

Date	median	Low	High	sales

Sales history

Last sale: —
30-day average: —
30-day low: —
30-day high: —
Sales 7d: 0
Sales 30d: 0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

From Wikipedia

Sunitinib, sold under the brand name Sutent, is an anti-cancer medication. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) in January 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications. As of August 2021, sunitinib is available as a generic medicine in the US.

Text: Wikipédia, CC BY-SA 4.0. · Image: Fvasconcellos (talk · contribs) (Public domain) ·

Related cards

Baricitinib

Chemical compound

Nº Q4860707 ★

Axitinib

Chemical compound

Nº Q4830631 ★

Osimertinib

Chemical compound, a third-generation epidermal growth factor receptor tyrosine kinase inhibitor, used as a medication to treat non-small-cell lung carcinomas with a specific mutation

Nº Q21506464 ★

Nintedanib

Chemical compound

Nº Q15149723 ★★

Imatinib

Chemical compound

Nº Q177094 ★★

Quinidine

Pharmaceutical agent that acts as a class I antiarrhythmic agent (Ia) in the heart

Nº Q412496 ★★